216 related articles for article (PubMed ID: 24048801)
1. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
3. Survival in advanced diffuse large B-cell lymphoma in pre- and post-rituximab Eras in the United States.
Shah BK; Bista A; Shafii B
Anticancer Res; 2014 Sep; 34(9):5117-20. PubMed ID: 25202101
[TBL] [Abstract][Full Text] [Related]
4. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
[TBL] [Abstract][Full Text] [Related]
5. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
6. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
7. Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.
Komrokji RS; Al Ali NH; Beg MS; Safa MM; Rollison D; Kharfan-Dabaja M; Bello C; Cultrera J; Sokol L; Pinilla-Ibarz J; Sotomayor EM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):257-60. PubMed ID: 21658652
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma.
O'Malley CD; Prehn AW; Shema SJ; Glaser SL
Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
11. Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes.
Bista A; Sharma S; Rijwani T; Shah BK
Anticancer Res; 2017 Apr; 37(4):1935-1939. PubMed ID: 28373463
[TBL] [Abstract][Full Text] [Related]
12. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.
MacDougall K; Day S; Hall S; Zhao D; Pandey M; Ibrahimi S; Khawandanah M; Chakrabarty JH; Asch A; Nipp R; Al-Juhaishi T
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):379-384. PubMed ID: 36813625
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of localized diffuse large B-cell lymphoma in younger patients.
Møller MB; Christensen BE; Pedersen NT
Cancer; 2003 Aug; 98(3):516-21. PubMed ID: 12879468
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
16. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
17. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
19. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
